Eric Flores
His priorities page has no health-care section. Under seniors it supports wider access to affordable prescription drugs, and under veterans wider access to VA care.
Election 2026 · Public beta
Independent, source-first accountability
Issue record
Campaign positions remain attributed. Official actions are shown separately, with narrow relationship labels and limits.
Campaign positions
His priorities page has no health-care section. Under seniors it supports wider access to affordable prescription drugs, and under veterans wider access to VA care.
His campaign supports a health-care system that works in cities and rural areas alike, including prevention, mental health and long-term care, and says no family should choose between medical care and basic needs.
No position on health care was found on his site or in his 2024 survey answers.
His platform would improve and expand Medicare for All, with no co-pays or premiums, covering vision, hearing aids, dental care and prescriptions.
Evidence timeline
official action
His campaign says he has introduced legislation to lower the cost of prescription drugs. The official text of the Drug Price Transparency in Medicaid Act names him among those who introduced it, twice. H.R. 6101 of December 1, 2021 reads "Mr. Carter of Georgia (for himself and Mr. Vicente Gonzalez of Texas) introduced the following bill", and H.R. 1613 of March 17, 2023 names him first after Carter; Congress.gov lists Carter as sponsor and Gonzalez as an original cosponsor of both. The bill curbs spread pricing by pharmacy benefit managers in Medicaid, and that provision passed the House as section 202 of the Lower Costs, More Transparency Act on December 11, 2023, 320-71, with his Yea (Roll Call 708). In 2025 he was an original cosponsor of the PBM Reform Act (H.R. 4317) and both Pharmacists Fight Back bills (H.R. 6609 and 6610). Three of the PBM Reform Act's six sections, on Medicare drug plans and employer health plans, became law almost word for word as sections 6223, 6224 and 6701 of the Consolidated Appropriations Act, 2026 (Public Law 119-75). He voted Yea when the House passed that act on January 22, 2026 (Roll Call 45) and Nay on the final House vote on February 3 (Roll Call 53). In all he has cosponsored more than twenty drug-price bills, among them the Elijah E. Cummings Lower Drug Costs Now Act in 2019, and voted for the Inflation Reduction Act, whose Medicare drug-price negotiation became law in 2022. Limit: The bill text uses his verb: it names him among the members who introduced the bill, though Carter was its sponsor and Gonzalez the lead cosponsor. None of the 55 items Congress.gov lists him as sponsoring concerns drug prices. The bill is aimed at what Medicaid pays for drugs, not at the price a patient pays. The Medicaid bill did not become law, and its spread-pricing section is not in the 2025 reconciliation act or the 2026 appropriations act. That act did carry most of the PBM Reform Act, though he voted against its final version.
official action
His campaign says that in 2021 he voted for historic legislation to cap the cost of insulin at $35 and bring down the cost of medicines. On November 19, 2021 he voted Yea on the Build Back Better Act (Roll Call 385, 220-213). As passed by the House it would have barred group health plans and individual insurance from charging more than $35 a month for selected insulin products from 2023. That bill did not become law. On August 12, 2022 he voted Yea on the Inflation Reduction Act (Roll Call 420), which limits Medicare cost-sharing for covered insulin products and became Public Law 117-169. Limit: The 2021 vote is as he describes it. The cap he voted for in 2021 reached private insurance; the cap that became law a year later covers Medicare only. Both votes split almost entirely by party; in 2021 one Democrat, Jared Golden of Maine, voted No.
official action
His campaign says that since coming to Congress he has voted down Republican efforts to dismantle the Affordable Care Act, Medicare and Social Security. In his first year he voted No on the American Health Care Act, the House bill to repeal and replace much of the Affordable Care Act, which passed 217-213 on May 4, 2017 (Roll Call 256) and did not become law. He also voted Nay at all three House votes on the Tax Cuts and Jobs Act, from November 16 to December 20, 2017 (Roll Calls 637, 692 and 699). It became Public Law 115-97, whose section 11081 cut the Affordable Care Act's penalty for going without coverage to zero from 2019. Limit: Two measures, four recorded votes, all in the direction the claim states; they do not score his whole record, and the Medicare and Social Security halves of the sentence are not tested by them. Both passed the House despite his votes: the first died in the Senate and the second became law, so "voted down" describes his votes, not the outcome.
See something wrong or incomplete? Report it for review.